Suppr超能文献

沙门氏菌O抗原的免疫化学。O9血清以及抗与牛血清白蛋白偶联的泰威糖(分子式:见正文)甘露糖抗体的特异性和交叉反应性。

Immunochemistry of Salmonella O-antigens. Specificity and cross-reactivity of factor O9 serum and of antibodies against tyvelose (Formula: see text) mannose coupled to bovine serum albumin.

作者信息

Jörbeck H, Carlsson H E, Svenson S B, Lindberg A A, Alfredsson G, Garegg P J, Svensson S, Wallin N H

出版信息

Int Arch Allergy Appl Immunol. 1979;58(1):11-9.

PMID:84796
Abstract

The octasaccharide Galp (Formula: see text) Rhap, the synthesized disaccharides methyl 3-O-a-tyvelopyranosyl-a-D-mannopyranoside, methyl 3-O-a-tyvelopyranosyl-beta-D-mannopyranoside and methyl alpha-tyveloside, in order of decreasing effectiveness, inhibited the precipitation of S. typhi T2 alkali-treated lipopolysaccharide by O-factor 9 serum. On a molar basis the relative inhibiting activities of the glycosides were by O-factor 9 serum. On a molar basis the relative inhibiting activities of the glycosides were 100:22:8:2. With rabbit aniserum raised against 3-O-a-tyvelopyranosyl-D-mannopyranosyl covalently linked to bovine serum albumin the relative inhibitory activities of the four glycosides were 11:100:26:3. These data establish that the 3-O-a-tyvelopyranosyl-a-D-mannopyranosyl structure is immunodominant in the Salmonella O-antigen 9. The specificity of the antigen-antibody interaction was high: glycosides in which the tyvelose (3,6-dideoxy-D-arabino-hexose) residue had been replaced by abequose (3,6-dideoxy-D-xylo-hexose) or paratose (3,6-dideoxy-K-ribo-hexose), had less than one fiftieth of the activity of the most active inhibitor in either of the two precipitation systems used. Moreover, the results show that 3-O-a-tyvelopyranosyl-D-mannopyranosyl coupled to bovine serum albumin elicits O-antibodies of higher specificity than those obtained by absorption of antibacterial immune serum.

摘要

八糖Galp(化学式:见正文)Rhap、合成的二糖3 - O - α - 泰威糖基 - α - D - 甘露吡喃糖苷、3 - O - α - 泰威糖基 - β - D - 甘露吡喃糖苷和α - 泰威糖甲基苷,按照效力递减的顺序,抑制了O因子9血清对伤寒沙门氏菌T2碱处理脂多糖的沉淀。以摩尔计,这些糖苷的相对抑制活性由O因子9血清决定。以摩尔计,糖苷的相对抑制活性为100:22:8:2。用针对与牛血清白蛋白共价连接的3 - O - α - 泰威糖基 - D - 甘露吡喃糖基产生的兔抗血清,这四种糖苷的相对抑制活性为11:100:26:3。这些数据表明3 - O - α - 泰威糖基 - α - D - 甘露吡喃糖基结构在沙门氏菌O抗原9中具有免疫显性。抗原 - 抗体相互作用的特异性很高:泰威糖(3,6 - 二脱氧 - D - 阿拉伯 - 己糖)残基被阿比可糖(3,6 - 二脱氧 - D - 木糖 - 己糖)或副糖(3,6 - 二脱氧 - K - 核糖 - 己糖)取代的糖苷,在所用的两种沉淀系统中,其活性均不到最活跃抑制剂的五十分之一。此外,结果表明与牛血清白蛋白偶联的3 - O - α - 泰威糖基 - D - 甘露吡喃糖基引发的O抗体比通过抗菌免疫血清吸收获得的抗体具有更高的特异性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验